Skip to main content

Routine IT maintenance on Wednesday, October 16 will cause service interruptions between midnight and 6:00am affecting the YourHealthNS app and on-line appointment booking including COVID-19 testing, blood collection, X-Ray, EKG and the Need a Family Practice Registry.  We apologize for any inconvenience.

 

Nova Scotia Health has made changes to parking and the main entrance of the QEII Halifax Infirmary. Learn more.

CAR T-Cell Therapy

Chimeric Antigen Receptor (or CAR) T-Cell Therapy is a new cancer immunotherapy that is delivered through Nova Scotia Cell Therapy and Transplant Program (CTTP). CAR T-Cell therapy involves separating specific immune cells from the patient’s own blood and genetically modifying them to recognize a specific marker on the cancer cells and then injecting them back to destroy these cells. This treatment is currently offered to patients diagnosed with relapsed or refractory Large B Cell Lymphomas who have failed their first and second lines of therapy.

T cells are collected from the patient and sent to an external manufacturing lab to create and grow CAR T cells. The final product is cryopreserved, packaged, and shipped back to the VG hospital in Halifax, ready to be infused back to the patient. The modified T cells then multiply in the body, targeting the cancer.

How do I prepare for my appointment?

Patients who are eligible for this treatment will be given an initial consult appointment. For this appointment, the patient should bring: - their health card and a list of current medications. It is important they also have a care partner present for this appointment.
A care partner is a responsible adult who will come with the patient to and from the hospital and helps as needed outside the hospital. Patients must have a care partner throughout the CAR T-Cell Therapy process.

What should I expect at my first appointment?

The initial consult appointment takes about 2 hours. The patient will meet with the CAR T-Cell Therapy Physician who will discuss this treatment option in detail. They will also spend time with a CAR T-Cell Therapy Coordinator who will provide information about the process.
The CAR T-Cell therapy team may ask questions to get to know you and will also provide you with time to ask your questions.
The CAR T-Cell Therapy Coordinator will arrange for you to meet with multiple members of our team who will provide care and support throughout. For example:

  • Nurse Practitioner
  • Social Worker
  • Pharmacist

Will there be any follow-up after my first appointment?

If you have met the eligibility criteria for CAR T-cell Therapy, a CAR T-Cell Therapy Coordinator will be in touch with you regarding any follow up tests, procedures, or appointments.

Learn More

Accessing this Clinic, Program or Service

CAR T-Cell Therapy is available at the following NSH locations:

A referral to the CAR T-Cell Therapy from a Hematologist is required to be evaluated for this treatment.

Patient Education Resources

Chimeric Antigen Receptor T-Cell Therapy

| .pdf

This pamphlet explains chimeric antigen receptor T-cell therapy (CAR T-cell therapy). Topics include phases of CAR T-cell therapy, staying in the hospital, program guidelines, the therapy schedule, and more.

Categories

Accessing Primary Care

There are many ways to access primary care, even if you're not currently attached to a primary care provider.

Answer a few quick questions to receive personalized instructions for accessing Nova Scotia Health's primary care options near you including in-person, virtual and telephone options.

Get Started

Find Emergency Care

Use this tool to identify the emergency care options that are currently available nearest to you.

If this is a medical emergency, please call 9-1-1 for immediate assistance

Get Started

©2024 Nova Scotia Health Authority. All rights reserved.